Analysts Offer Insights on Healthcare Companies: Cardiff Oncology (CRDF) and Alphatec Holdings (ATEC)
There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Cardiff Oncology (CRDF – Research Report) and Alphatec Holdings (ATEC – Research Report) with bullish sentiments.
Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Cardiff Oncology (CRDF)
In a report released yesterday, Marc Frahm from TD Cowen maintained a Buy rating on Cardiff Oncology. The company’s shares closed last Tuesday at $1.70.
According to TipRanks.com, Frahm is a 5-star analyst with an average return of
Cardiff Oncology has an analyst consensus of Strong Buy, with a price target consensus of $11.00, implying a 600.6% upside from current levels. In a report released today, William Blair also reiterated a Buy rating on the stock.
See today’s best-performing stocks on TipRanks >>
Alphatec Holdings (ATEC)
TD Cowen analyst Mathew Blackman assigned a Buy rating to Alphatec Holdings yesterday and set a price target of $20.00. The company’s shares closed last Tuesday at $13.93, close to its 52-week high of $14.54.
According to TipRanks.com, Blackman is a 4-star analyst with an average return of
The word on The Street in general, suggests a Strong Buy analyst consensus rating for Alphatec Holdings with a $24.33 average price target.
